Molecular Definition of Breast Tumor Heterogeneity

Michail Shipitsin, Lauren L. Campbell, Pedram Argani, +18

Cancer Cell

Disease HeterogeneityBreast OncologyTumor HeterogeneityPathologyBreast Cancer +4

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

Yuchen Jiao, Timothy M. Pawlik, Robert A. Anders, +33

Nature Genetics

Tumor BiologyOncologyHepatologySomatic VariantMedicine +10

The PIK3CA gene is mutated with high frequency in human breast cancers

Kurtis E. Bachman, Pedram Argani, Yardena Samuels, +10

Cancer Biology & Therapy

Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.

Robb E. Wilentz, Christine A. Iacobuzio–Donahue, Pedram Argani, +5

PubMed

ImmunologyPathologyPancreatic Intraepithelial NeoplasiaDpc4 InactivationDpc4 Expression +14

Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers

Michael C. Haffner, Alcides Chaux, Alan K. Meeker, +10

Oncotarget

Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer

Julia A. Beaver, Danijela Jelovac, Balukrishna Sasidharan, +26

Clinical Cancer Research

Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast

Brian Cornblatt, Lingxiang Ye, Albena T. Dinkova‐Kostova, +11

Carcinogenesis

Detection of Tumor <i>PIK3CA</i> Status in Metastatic Breast Cancer Using Peripheral Blood

Michaela J. Higgins, Danijela Jelovac, Evan Barnathan, +20

Clinical Cancer Research

Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition

Dingcheng Gao, Natasha Joshi, Hyejin Choi, +13

Cancer Research

Molecular markers in ductal carcinoma in situ of the breast.

Dale Porter, Jaana Lahti‐Domenici, Aparna Keshaviah, +11

PubMed

Breast OncologyEngineeringMolecular MarkersPathologyGene Expression Profiling +16